Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Circ Heart Fail. 2013 Jul;6(4):862–868. doi: 10.1161/CIRCHEARTFAILURE.113.000394

Table 2. Dose Adjustment with Renal Dysfunction.

Visit (Time) SCr ≤ 2 mg/dl SCr > 2, but ≤ 3 mg/dl SCr > 3, but < 5 mg/dl SCr ≥ 5 mg/dl
0 (Baseline)* 300 mg 100 mg Excluded Excluded
1 (7-10 Days)* 600 mg 300 mg --- ---
2 (4 Weeks) 600 mg 300 mg 100 mg Discontinue
4 (12 Weeks) 600 mg 300 mg 100 mg Discontinue

SCr, serum creatinine level.

*

Screening laboratories used to determine dosing at baseline and visit 1;

laboratories are not checked at this visit, which is a telephone call;

if renal function improves at visit 2 or 4, subjects remain at established dose (i.e., no up-titration).